Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
16.26
-0.55 (-3.27%)
Dec 5, 2025, 4:00 PM EST - Market closed

Eton Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
43635511271106197
Upgrade
Market Cap Growth
60.74%215.68%57.54%-32.42%-46.38%53.54%
Upgrade
Enterprise Value
430339966490197
Upgrade
Last Close Price
16.2613.324.382.824.298.13
Upgrade
Forward PE
16.5157.9179.64-9.98-
Upgrade
PS Ratio
6.179.093.553.364.845047.59
Upgrade
PB Ratio
18.8614.527.265.465.9912.57
Upgrade
P/TBV Ratio
--10.478.577.5413.05
Upgrade
P/FCF Ratio
20.75376.2216.4914.92--
Upgrade
P/OCF Ratio
20.46366.1316.4914.80--
Upgrade
EV/Sales Ratio
6.118.693.043.034.115040.62
Upgrade
EV/FCF Ratio
20.45359.3214.1113.46--
Upgrade
Debt / Equity Ratio
1.341.230.350.500.380.46
Upgrade
Debt / FCF Ratio
1.4731.810.801.36--
Upgrade
Asset Turnover
1.000.721.120.810.810.00
Upgrade
Inventory Turnover
3.251.9314.4212.533.160.54
Upgrade
Quick Ratio
1.141.021.532.814.365.63
Upgrade
Current Ratio
1.632.061.653.105.186.51
Upgrade
Return on Equity (ROE)
-34.17%-19.16%-6.56%-58.75%-11.74%-213.40%
Upgrade
Return on Assets (ROA)
1.26%-2.53%-2.63%-19.67%-3.47%-78.10%
Upgrade
Return on Capital (ROIC)
2.37%-3.62%-3.68%-23.51%-3.96%-89.38%
Upgrade
Return on Capital Employed (ROCE)
2.30%-3.90%-7.70%-44.50%-6.50%-120.40%
Upgrade
Earnings Yield
-1.53%-1.08%-0.83%-12.65%-1.85%-14.21%
Upgrade
FCF Yield
4.82%0.27%6.06%6.71%-4.48%-11.38%
Upgrade
Buyback Yield / Dilution
-3.52%-0.97%-1.99%0.24%-19.98%-18.30%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.